Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleR

Cancer-related Issues of CD147

ULRICH H. WEIDLE, WERNER SCHEUER, DANIELA EGGLE, STEFAN KLOSTERMANN and HANNES STOCKINGER
Cancer Genomics & Proteomics May 2010, 7 (3) 157-169;
ULRICH H. WEIDLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WERNER SCHEUER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIELA EGGLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN KLOSTERMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANNES STOCKINGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Topology of human CD147 isoforms. The most frequently expressed variant of CD147 (2 Ig-like domain form) is shown on the left, the rarely expressed CD147 variant (3 Ig-like domain form) is shown on the right. Modules, N-glycosylation sites, phosphoserine residues and isoform-specific amino acids are highlighted according to the Swissprot entry BASI_HUMAN.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Amino acid sequence and functional motifs of human CD147. Domains and motifs are highlighted by a color code as outlined. The positions of the Ig-like domains are labeled according to Interpro Prosite PROFILE PS50835, that of the first Ig-like domain and the disulfide bridges according to Interpro SMART SM00408. All other annotations are based on the Swissprot entry BASI_HUMAN.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Amino acid sequence alignment of CD147 from different species (orthologs). Identical amino acids are indicated by a light blue background, Ig-like C2-type domains, Ig-like V-type domains and the transmembrane domains are boxed by dark blue, green and black colors, respectively. Chimp and rhesus sequences are predicted based on their genome sequences, the other sequences were derived from the Swissprot dada base (BASI_X).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Amino acid sequences of human CD147 and its paralogs Neuroplastin and Embigin. Identical amino acids are indicated by light blue color and the transmembrane domains are highlighted by a black box. The sequences are derived from the Swissprot databases: BASI_HUMAN, NPTN_HUMAN, EMB_HUMAN.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Schematic overview of CD147-associated proteins, mediators of signaling and transcriptionally induced genes. Details are given in the text. HSPG, Heparan-sulfate proteoglycan; FAK, focal adhesion kinase; MEK, Map-Erk kinase; ERK, extracellular signal-related kinases; Akt, serine-threonine kinase; MMP, matrix metalloproteinase; VEGF, vascular endothelial growth factor; α3β1 and α6β1, integrins; MCT, monocarbocylate transporter; LAT1, large neutral amino acid transporter; CD98, subunit of LAT1; ASC2, Asc-type amino acid transporter-2.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    CD147 neighbourhood analysis. Ingenuity pathway analysis (IPA) was used to create the neighborhood of genes for CD147. Shown are all molecules with a direct relationship to CD147. Edges are annotated by the relationship type of two molecules: PP, protein-protein interaction; E expression; P, phosphorylation; LO, location; PD, protein DNA interaction; TR, translocation; A, activation. All neighboring molecules of CD147 were manually grouped and annotated according to their molecular type. MMP1/2/3, matrix metalloproteinases 1/2/3; NCSTN, nicastrin; Mmp, group of matrix metalloproteinases; RFXANK, regulatory factor X-associated ankyrin-containing protein; STAT4, signal transducer and activator of transcription; RYR1, ryanodine receptor 1; PTPN11, protein tyrosine phosphatase, non-receptor type 11; NT5C3, 5'-nucleotidase, cytosolic III; SLC2A4, solute carrier family 2, member 4; SLC16A4, solute carrier family 16, member 4; SLC16A1, solute carrier family 16, member 1; ATP1B2, ATPase, Na+/K+ transporting, beta 2 polypeptide; ATP1A2, ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide; SCP2, sterol carrier protein 2; AJAP1, adherens junctions-associated protein 1; MCTS1, malignant T-cell amplified sequence 1; APP, amyloid beta (A4) precursor protein; RANBP3, RAN binding protein 3; ATXN10, ataxin 10; PDLIM7, PDZ and LIM domain 7; PRNP, prion protein; BAD, BCL2-associated agonist of cell death; PNN, pinin, desmosome-associated protein; BCL2L11, BCL2-like 11; PPIA/PPIC, peptidylprolyl isomerase A/C (cyclophilin A/C); LEP, leptin; CSF2, colony-stimulating factor 2; SPP1, secreted phosphoprotein 1; Pkc(s), group of protein kinases c; ERK1/2, group of ERKs; ERK, group of ERKs; Akt, group of Akts; MAP2K1/2, mitogen-activated protein kinase kinase group of kinases.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    RNA-based CD147 expression in liver cancer and bladder cancer in comparison to corresponding normal tissues. Comparison of CD147 expression signals between tumor-related and normal tissues for (A) liver and (B) bladder. Gene expression data were derived from the GEO database [liver (GSE6764), bladder (GSE3167)]. These relative units of expression sets exemplify results obtained from several distinct studies (GSE1898, GSE6222, GSE5364 for liver and GSE7476, E-TABM-147 for bladder); n depicts the number of biological samples within each group. HCC, Hepatocellular carcinoma; CIS, carcinoma in situ; sTCC, superficial transitional cell carcinoma; mTCC, muscle invasive transitional cell carcinoma.

PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 7 (3)
Cancer Genomics & Proteomics
Vol. 7, Issue 3
May-June 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cancer-related Issues of CD147
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cancer-related Issues of CD147
ULRICH H. WEIDLE, WERNER SCHEUER, DANIELA EGGLE, STEFAN KLOSTERMANN, HANNES STOCKINGER
Cancer Genomics & Proteomics May 2010, 7 (3) 157-169;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cancer-related Issues of CD147
ULRICH H. WEIDLE, WERNER SCHEUER, DANIELA EGGLE, STEFAN KLOSTERMANN, HANNES STOCKINGER
Cancer Genomics & Proteomics May 2010, 7 (3) 157-169;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • General Features of CD147
    • Induction of MMP Is a Cancer-related Feature of CD147
    • CD147 Mediates MMP-dependent and -independent Angiogenesis
    • CD147 Association with Cyclophilins (Cyps)
    • Target Validation Experiments with RNAi Reveal Functional CD147/MCT Interactions
    • Association of CD147 with Caveolin and Integrins
    • Function of CD147 as an Anti-apoptotic Protein and Mediator of Chemoresistance
    • Expression of CD147 in Cancer
    • Antibodies Directed against CD147
    • CD147 as a Target for Treatment of Cancer
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Dynamic Interaction- and Phospho-Proteomics Reveal Lck as a Major Signaling Hub of CD147 in T Cells
  • How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
  • Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies
  • HAb18G/CD147 Promotes Radioresistance in Hepatocellular Carcinoma Cells: A Potential Role for Integrin {beta}1 Signaling
  • HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s
  • CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
  • CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
  • The role of amino acid transporters in inherited and acquired diseases
  • Google Scholar

Similar Articles

Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire